Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CardieX ( (AU:CDX) ) just unveiled an update.
CardieX Limited has announced a change in the director’s interest, specifically involving Charlie Taylor, who has acquired additional securities through the CW Taylor Family Trust. This acquisition was part of a director placement approved at the company’s May 2025 Extraordinary General Meeting, reflecting strategic financial maneuvers that could influence the company’s market position and shareholder value.
More about CardieX
CardieX Limited operates in the medical technology industry, focusing on the development and commercialization of cardiovascular health solutions. The company is known for its innovative products aimed at improving heart health and monitoring, catering to both consumer and clinical markets.
Average Trading Volume: 244,250
Technical Sentiment Signal: Sell
Current Market Cap: A$21.07M
For a thorough assessment of CDX stock, go to TipRanks’ Stock Analysis page.